ATWOOD BRIAN G

CIK 000126656720 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001266567

Recent Transactions

50 trades

Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2026-01-07+1,612,099→ 1,612,099 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-05-30+122,549→ 122,549 total
Exercise/Conversion
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Pre-Funded Warrant
2025-03-31$0.00/sh+294,460→ 11,660 total
Exercise/Conversion
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2025-03-31$0.00/sh+294,460→ 490,534 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-03-04+14,936→ 14,936 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-02-24+254,000→ 508,000 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Warrant to Purchase Shares of Common Stock
2025-02-07$1.96/sh+204,080→ 204,080 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Pre-Funded Warrant
2025-02-07$0.00/sh+204,080→ 204,080 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Warrant to Purchase Shares of Common Stock
2025-02-07$1.96/sh+306,120→ 306,120 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Pre-Funded Warrant
2025-02-07$0.00/sh+306,120→ 306,120 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-12-02+254,000→ 254,000 total
Disposition to Issuer
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-09-30−1,317,956→ 0 total
Disposition to Issuer
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-09-30−13,857→ 0 total
Exercise/Conversion
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Series A Convertible Preferred Stock
2024-09-25$1000.00/sh−1,002→ 0 total
Exercise/Conversion
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-09-25+19,358,578→ 19,607,313 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-03-25+1,317,956→ 1,317,956 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14+100,527→ 100,527 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Series A Convertible Preferred Stock
2024-02-14$1000.00/sh+1,002→ 1,002 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14+125,000→ 125,000 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14+148,208→ 248,735 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14+148,208→ 248,735 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14+148,208→ 248,735 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Series A Convertible Preferred Stock
2024-02-14$1000.00/sh+1,002→ 1,002 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Series A Convertible Preferred Stock
2024-02-14$1000.00/sh+1,002→ 1,002 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14+100,527→ 100,527 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Common Stock
2024-02-14+100,527→ 100,527 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-02-14+13,857→ 13,857 total
Award
Atreca, Inc.
Stock Option (right to buy)
2023-06-13+12,000→ 12,000 total
Award
Atreca, Inc.
Stock Option (right to buy)
2022-06-08+12,000→ 12,000 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Class B Common Stock
2021-10-08+25,000→ 25,000 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2021-06-10+42,223→ 42,223 total
Award
Atreca, Inc.
Stock Option (right to buy)
2021-06-09+12,000→ 12,000 total
Other
eFFECTOR Therapeutics, Inc.
Class B Common Stock
2021-01-12−25,000→ 25,000 total
Gift
Atreca, Inc.
Stock Option (right to buy)
2020-12-09−12,500→ 0 total
Gift
Atreca, Inc.
Stock Option (right to buy)
2020-12-09+12,500→ 12,500 total
Gift
Atreca, Inc.
Stock Option (right to buy)
2020-12-09+34,166→ 34,166 total
Gift
Atreca, Inc.
Stock Option (right to buy)
2020-12-09+12,000→ 12,000 total
Gift
Atreca, Inc.
Stock Option (right to buy)
2020-12-09−12,000→ 0 total
Gift
Atreca, Inc.
Stock Option (right to buy)
2020-12-09−34,166→ 0 total
Exercise/Conversion
Clovis Oncology, Inc.
Stock Option (right to buy)
2020-11-09−6,896→ 0 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2020-11-09$3.08/sh+6,896→ 32,758 total
Award
Atreca, Inc.
Stock Option (right to buy)
2020-06-10+12,000→ 12,000 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2020-06-04+40,138→ 40,138 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2019-08-20$0.29/sh+25,862→ 25,862 total
Exercise/Conversion
Clovis Oncology, Inc.
Stock Option (right to buy)
2019-08-20−25,862→ 0 total
Conversion
Atreca, Inc.
Series B Preferred Stock
2019-06-24−4,287→ 0 total
Conversion
Atreca, Inc.
Class A Common Stock
2019-06-24+8,791→ 49,654 total
Conversion
Atreca, Inc.
Series A Preferred Stock
2019-06-24−4,504→ 0 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2019-06-06+28,882→ 2,882 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2018-10-11+14,770→ 14,770 total

Recent Filings

Address

CERO THERAPEUTICS HOLDINGS, INC. 201 HASKINS WAY, SUITE 230

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov